Systematic identification of type I and type II interferon-induced antiviral factors
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Type I and type II interferons (IFNs) are cytokines that establish the cellular antiviral state through the induction of IFN-stimulated genes (ISGs). We sought to understand the basis of the antiviral activity induced by type I and II IFNs in relation to the functions of their ISGs. Based on gene expression studies, we systematically identified antiviral ISGs by performing blinded, functional screens on 288 type I and type II ISGs. We assessed and validated the antiviral activity of these ISGs against an RNA virus, vesicular stomatitis virus (VSV), and a DNA virus, murine gammaherpes virus (MHV-68). Overall, we identified 34 ISGs that elicited an antiviral effect on the replication of either one or both viruses. Fourteen ISGs have uncharacterized antiviral functions. We further defined ISGs that affect critical life-cycle processes in expression of VSV protein and MHV-68 immediate-early genes. Two previously undescribed antiviral ISGs, TAP1 and BMP2, were further validated. TAP1-deficient fibroblasts were more susceptible to VSV infection but less so to MHV-68 infection. On the other hand, exogenous BMP2 inhibits MHV-68 lytic growth but did not affect VSV growth. These results delineate common and distinct sets of type I and type II IFN-induced genes as well as identify unique ISGs that have either broad or specific antiviral effects on these viruses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interferon-γ: an overview of signals, mechanisms and functions
Schroder, K., Hertzog, P. J., Ravasi, T., & Hume, D. A. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0603252 · Cited by 4,120 · cited 2×
“IFNγ receptor (IFNGR) activation leads to phosphorylation and homodimerization of STAT1 and target gene expression (3).”
BackgroundFunctional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453
A diverse range of gene products are effectors of the type I interferon antiviral response
Schoggins, J. W., Wilson, S. J., Panis, M., Murphy, M. Y., Jones, C. T., Bieniasz, P., & Rice, C. M. (2011) · Nature · doi:10.1038/nature09907 · Cited by 2,433
Interferon-inducible antiviral effectors
Sadler, A. J., & Williams, B. R. G. (2008) · Nature Reviews Immunology · doi:10.1038/nri2314 · Cited by 2,160
Yoneyama, M., Kikuchi, M., Matsumoto, K., Imaizumi, T., Miyagishi, M., Taira, K., Foy, E., Loo, Y.-M., Gale, M., Akira, S., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.5.2851 · Cited by 1,689
Meraz, M. A., White, J. M., Sheehan, K. C. F., Bach, E. A., Rodig, S. J., Dighe, A. S., Kaplan, D. H., Riley, J. K., Greenlund, A. C., Campbell, D., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81288-x · Cited by 1,656 · cited 6×
“STAT1 can homodimerize or heterodimerize with STAT2 and translocate into the nucleus to activate specific target promoters (2).”
BackgroundInfluentialMiyamoto, M., Fujita, T., Kimura, Y., Maruyama, M., Harada, H., Sudo, Y., Miyata, T., & Taniguchi, T. (1988) · Cell · doi:10.1016/s0092-8674(88)91307-4 · Cited by 978
Zarnegar, B. J., Wang, Y., Mahoney, D. J., Dempsey, P. W., Cheung, H. H., He, J., Shiba, T., Yang, X., Yeh, W.-C., Mak, T. W., et al. (2008) · Nature Immunology · doi:10.1038/ni.1676 · Cited by 604
Self-citationA system for functional analysis of Ebola virus glycoprotein
Takada, A., Robison, C., Goto, H., Sanchez, A., Murti, K. G., Whitt, M. A., & Kawaoka, Y. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14764 · Cited by 575
EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus
Negrete, O. A., Levroney, E. L., Aguilar, H. C., Bertolotti-Ciarlet, A., Nazarian, R., Tajyar, S., & Lee, B. (2005) · Nature · doi:10.1038/nature03838 · Cited by 570
Cited by
Molecular and genetic properties of tumors associated with local immune cytolytic activity
Rooney, M. S., Shukla, S. A., Wu, C. J., Getz, G., & Hacohen, N. (2015) · Cell · doi:10.1016/j.cell.2014.12.033 · Cited by 3,825
Mechanisms of SARS-CoV-2 entry into cells
Jackson, C. B., Farzan, M., Chen, B., & Choe, H. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00418-x · Cited by 3,022
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Hadjadj, J., Yatim, N., Barnabei, L., Corneau, A., Boussier, J., Smith, N., Péré, H., Charbit, B., Bondet, V., Chenevier-Gobeaux, C., et al. (2020) · Science · doi:10.1126/science.abc6027 · Cited by 2,984
NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential
Xie, N., Zhang, L., Gao, W., Huang, C., Huber, P. E., Zhou, X., Li, C., Shen, G., & Zou, B. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00311-7 · Cited by 1,052
Interferon-Stimulated Genes: What Do They All Do?
Schoggins, J. W. (2019) · Annual Review of Virology · doi:10.1146/annurev-virology-092818-015756 · Cited by 1,036
Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity
Schoggins, J. W., MacDuff, D. A., Imanaka, N., Gainey, M. D., Shrestha, B., Eitson, J. L., Mar, K. B., Richardson, R. B., Ratushny, A. V., Litvak, V., et al. (2014) · Nature · doi:10.1038/nature12862 · Cited by 896
Liu, S.-Y., Aliyari, R., Chikere, K., Li, G., Marsden, M. D., Smith, J. K., Pernet, O., Guo, H., Nusbaum, R., Zack, J. A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2012.11.005 · Cited by 678
“In a previous study, we performed a blinded, unbiased screen for antiviral ISGs against vesicular stomatitis virus co-expressing GFP (VSV-GFP) (Liu et al., 2012).”
MethodSelf-citationType I interferon response drives neuroinflammation and synapse loss in Alzheimer disease
Roy, E. R., Wang, B., Wan, Y.-W., Chiu, G., Cole, A., Yin, Z., Propson, N. E., Xu, Y., Jankowsky, J. L., Liu, Z., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci133737 · Cited by 563
Host Immune Response to Influenza A Virus Infection
Chen, X., Liu, S., Goraya, M. U., Maarouf, M., Huang, S., & Chen, J.-L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00320 · Cited by 462
Self-citation25-Hydroxycholesterol suppresses interleukin-1–driven inflammation downstream of type I interferon
Reboldi, A., Dang, E. V., McDonald, J. G., Liang, G., Russell, D. W., & Cyster, J. G. (2014) · Science · doi:10.1126/science.1254790 · Cited by 444
Chiche, L., Jourde‐Chiche, N., Whalen, E., Presnell, S., Gersuk, V., Dang, K., Anguiano, E., Quinn, C., Burtey, S., Berland, Y., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38628 · Cited by 420
Blanc, M., Hsieh, W. Y., Robertson, K. A., Kropp, K. A., Forster, T., Shui, G., Lacaze, P., Watterson, S., Griffiths, S. J., Spann, N. J., et al. (2013) · Immunity · doi:10.1016/j.immuni.2012.11.004 · Cited by 411
25-Hydroxycholesterols in innate and adaptive immunity
Cyster, J. G., Dang, E. V., Reboldi, A., & Yi, T. (2014) · Nature Reviews Immunology · doi:10.1038/nri3755 · Cited by 388
Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity
Meier, P., Legrand, A. J., Adam, D., & Silke, J. (2024) · Nature Reviews Cancer · doi:10.1038/s41568-024-00674-x · Cited by 382
Translation inhibition and stress granules in the antiviral immune response
McCormick, C., & Khaperskyy, D. A. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.63 · Cited by 353
Li, C., Deng, Y.-Q., Wang, S., Ma, F., Aliyari, R., Huang, X.-Y., Zhang, N.-N., Watanabe, M., Dong, H.-L., Liu, P., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.02.012 · Cited by 344
Self-citationThe Interferon-Inducible MxB Protein Inhibits HIV-1 Infection
Liu, Z., Pan, Q., Ding, S., Qian, J., Xu, F., Zhou, J., Cen, S., Guo, F., & Liang, C. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.08.015 · Cited by 334
Interferon-stimulated genes: roles in viral pathogenesis
Schoggins, J. W. (2014) · Current Opinion in Virology · doi:10.1016/j.coviro.2014.03.006 · Cited by 314
DNA Sensing in Mismatch Repair-Deficient Tumor Cells Is Essential for Anti-tumor Immunity
Lu, C., Guan, J., Lu, S., Jin, Q., Rousseau, B., Lu, T., Stephens, D., Zhang, H., Zhu, J., Yang, M., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2020.11.006 · Cited by 285
HIV-1 and interferons: who's interfering with whom?
Doyle, T., Goujon, C., & Malim, M. H. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3449 · Cited by 285
Antiviral Activity of Human OASL Protein Is Mediated by Enhancing Signaling of the RIG-I RNA Sensor
Zhu, J., Zhang, Y., Ghosh, A., Cuevas, R. A., Forero, A., Dhar, J., Ibsen, M. S., Schmid-Burgk, J. L., Schmidt, T., Ganapathiraju, M. K., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.05.007 · Cited by 272
Naujoks, J., Tabeling, C., Dill, B. D., Hoffmann, C., Brown, A. S., Kunze, M., Kempa, S., Peter, A., Mollenkopf, H.-J., Dorhoi, A., et al. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005408 · Cited by 261
Leonova, K. I., Brodsky, L., Lipchick, B., Pal, M., Novototskaya, L., Chenchik, A. A., Sen, G. C., Komarova, E. A., & Gudkov, A. V. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216922110 · Cited by 261
Glycyrrhizic‐Acid‐Based Carbon Dots with High Antiviral Activity by Multisite Inhibition Mechanisms
Tong, T., Hu, H., Zhou, J., Deng, S., Zhang, X., Tang, W., Fang, L., Xiao, S., & Liang, J. (2020) · Small · doi:10.1002/smll.201906206 · Cited by 249
Sacco, K., Castagnoli, R., Vakkilainen, S., Liu, C., Delmonte, O. M., Oguz, C., Kaplan, I. M., Alehashemi, S., Burbelo, P. D., Bhuyan, F., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01724-3 · Cited by 247
Negative regulation of the interferon response by an interferon-induced long non-coding RNA
Kambara, H., Niazi, F., Kostadinova, L., Moonka, D. K., Siegel, C. T., Post, A. B., Carnero, E., Barriocanal, M., Fortes, P., Anthony, D. D., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku713 · Cited by 232
“To determine if the impact of lncRNA-CMPK2 knockdown on HCV replication was mediated through direct modulation of the IFN response, we analyzed the IFNstimulated expression level of a number of protein-coding ISGs with known antiviral activity against HCV (60–62).”
BackgroundInfluentialCzarnowicki, T., Gonzalez, J., Shemer, A., Malajian, D., Xu, H., Zheng, X., Khattri, S., Gilleaudeau, P., Sullivan-Whalen, M., Suárez-Fariñas, M., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.01.020 · Cited by 221
The impact of PARPs and ADP-ribosylation on inflammation and host–pathogen interactions
Fehr, A. R., Singh, S. A., Kerr, C. M., Mukai, S., Higashi, H., & Aikawa, M. (2020) · Genes & Development · doi:10.1101/gad.334425.119 · Cited by 214
“…involve the interplay between PARP1 and nuclear factor κB (NF-κB), a key 342 GENES & DEVELOPMENT transcription factor in immunity and various other biological processes (Hassa and Hottiger 1999; Hassa et al. 2005; Liu et al. 2012a; Minotti et al. 2015; Bohio et al. 2019; Kunze and Hottiger 2019).”
BackgroundInfluentialKDM5 histone demethylases repress immune response via suppression of STING
Wu, L., Cao, J., Cai, W. L., Lang, S. M., Horton, J. R., Jansen, D. J., Liu, Z. Z., Chen, J. F., Zhang, M., Mott, B. T., et al. (2018) · PLOS Biology · doi:10.1371/journal.pbio.2006134 · Cited by 172
Positive Feedback Regulation of Type I IFN Production by the IFN-Inducible DNA Sensor cGAS
Ma, F., Li, B., Liu, S.-Y., Iyer, S. S., Yu, Y., Wu, A., & Cheng, G. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402066 · Cited by 166
“By analyzing the gene expression profile of the IFN-I– and type II IFN (IFN-II)–stimulated BMMs (5), we found that cGAS mRNA expression was significantly upregulated in IFN-a–treated BMMs (Fig.”
BackgroundInfluentialSelf-citationPetrolatum: Barrier repair and antimicrobial responses underlying this “inert” moisturizer
Czarnowicki, T., Malajian, D., Khattri, S., Correa da Rosa, J., Dutt, R., Finney, R., Dhingra, N., Xiangyu, P., Xu, H., Estrada, Y. D., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.08.013 · Cited by 161
ATF3 Is a Key Regulator of Macrophage IFN Responses
Labzin, L. I., Schmidt, S. V., Masters, S. L., Beyer, M., Krebs, W., Klee, K., Stahl, R., Lütjohann, D., Schultze, J. L., Latz, E., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500204 · Cited by 124
The role of alternative polyadenylation in the antiviral innate immune response
Jia, X., Yuan, S., Wang, Y., Fu, Y., Ge, Y., Ge, Y., Lan, X., Feng, Y., Qiu, F., Li, P., et al. (2017) · Nature Communications · doi:10.1038/ncomms14605 · Cited by 122
Gerbino, V., Kaunga, E., Ye, J., Canzio, D., O’Keeffe, S., Rudnick, N. D., Guarnieri, P., Lutz, C. M., & Maniatis, T. (2020) · Neuron · doi:10.1016/j.neuron.2020.03.005 · Cited by 102
Cholesterol metabolism: from lipidomics to immunology
Griffiths, W. J., & Wang, Y. (2022) · Journal of Lipid Research · doi:10.1016/j.jlr.2021.100165 · Cited by 68
Metadata
- Authors
- Liu, S.-Y., Sanchez, D. J., Aliyari, R., Lu, S., & Cheng, G.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2012-02-27
- Volume
- 109
- Issue
- 11
- Pages
- 4239-4244
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2144206275
- Cited by
- 445
- References
- 23
- FWCI
- 12.33
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.